US20030101800A1 - Balloon catheter leak detection method and apparatus - Google Patents
Balloon catheter leak detection method and apparatus Download PDFInfo
- Publication number
- US20030101800A1 US20030101800A1 US10/341,983 US34198303A US2003101800A1 US 20030101800 A1 US20030101800 A1 US 20030101800A1 US 34198303 A US34198303 A US 34198303A US 2003101800 A1 US2003101800 A1 US 2003101800A1
- Authority
- US
- United States
- Prior art keywords
- balloon
- pressure
- balloon catheter
- gas
- processor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01M—TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR
- G01M3/00—Investigating fluid-tightness of structures
- G01M3/02—Investigating fluid-tightness of structures by using fluid or vacuum
- G01M3/26—Investigating fluid-tightness of structures by using fluid or vacuum by measuring rate of loss or gain of fluid, e.g. by pressure-responsive devices, by flow detectors
- G01M3/32—Investigating fluid-tightness of structures by using fluid or vacuum by measuring rate of loss or gain of fluid, e.g. by pressure-responsive devices, by flow detectors for containers, e.g. radiators
- G01M3/3218—Investigating fluid-tightness of structures by using fluid or vacuum by measuring rate of loss or gain of fluid, e.g. by pressure-responsive devices, by flow detectors for containers, e.g. radiators for flexible or elastic containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/295—Balloon pumps for circulatory assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/497—Details relating to driving for balloon pumps for circulatory assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/515—Regulation using real-time patient data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/538—Regulation using real-time blood pump operational parameter data, e.g. motor current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/15—Detection of leaks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/135—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
Definitions
- the invention relates to a leak detector for a pressurized device. More particularly, the invention relates to a detector for detecting a gas leak from an intra-aortic balloon (“IAB”) catheter system.
- IAB intra-aortic balloon
- a long cylindrical intra-aortic balloon is inserted percutaneously into a patient's femoral artery. The balloon is then advanced until it is located in the descending aorta. Once in place, the balloon is inflated and deflated anti-phase to the pumping action of the patient's left ventricle, i.e. the balloon is held inflated during at least a portion of diastole and is held deflated during at least a portion of systole.
- the IAB catheter is connected to a pump (IABP) for inflation and deflation of the balloon membrane on the distal end of the catheter.
- IABP pump
- IAB therapy is most effective when the transitions between the inflated and deflated states of the balloon membrane are rapid, typically, less than 0.1 second.
- coronary blood flow is increased and cardiac work is decreased. This lifesaving therapy supports the heart during ischemic events or cardiogenic shock.
- the IAB balloon When sized for adult patients, the IAB balloon typically has a volume of 40 cubic centimeters.
- a small diameter catheter having an outside diameter of less than 0.1 inches (2.5 mm) is integral to the IAB.
- the catheter provides pneumatic access to the IAB.
- the catheter's diameter is small to reduce its impact upon blood flow in the patient's femoral artery.
- the catheter's small internal diameter impedes the flow of shuttle gas to and from the IAB balloon.
- the catheter's pressure drop at the catheter and balloon junction is large because the gas velocity in the catheter is high, approximately 500 ft/sec.
- helium gas is used as the working (shuttle) gas to inflate and deflate the IAB; and (2) a larger diameter “extension” catheter is used to interconnect the IAB's catheter to the intra-aortic balloon pump's pneumatic port.
- the extension catheter's diameter is larger, and thus, it's pressure drop is lower.
- the shuttle gas is pressurized and de-pressurized each heartbeat by the IAB pump.
- the sources of the pressure changes are the pump and the restriction of the IAB's catheter.
- heat energy is stored in the shuttle gas, and on each deflation, heat is released.
- the shuttle gas pressure changes as it attempts to thermally equilibrate with its environment.
- the pressure decays toward the appropriate average shuttle pressure in an exponential manner with a time constant on the order of approximately 1 second.
- durations of IAB inflation and deflation are too brief, i.e. the shuttle gas is re-compressed before it “recovers” from deflation and vice versa.
- the durations of the deflate and inflate intervals are approximately 0.375 seconds at a typical patient heart rate of 80 beats per minute.
- the duration of the deflate interval is defined as the duration the balloon remains in the deflated state during systole plus the amount of time it takes for the balloon to deflate.
- the duration of the inflate interval is defined as the duration the balloon remains in the inflated state during diastole plus the amount of time it takes for the balloon to inflate.
- IABP systems have a shuttle gas pressure sensor.
- the shuttle gas pressure is measured when the IAB is in its deflated state. This assures that the gas resides in the more stable and predicable geometries of the catheter(s) and intra-aortic balloon pump's drive.
- the shuttle gas pressure is measured as “late” as possible after IAB deflation. This maximizes the time interval available for IAB deflation.
- the shuttle gas is no longer moving and the “static” criteria is met. This corresponds to measuring the pressure just prior to IAB inflation.
- shuttle gas temperature is the sum of two components, a local ambient temperature component and a thermal transient component, due to gas compression and decompression. Temperature sensors with the necessary speed of response to measure the thermal transients are fragile and expensive. For this reason, shuttle temperature is not measured by most IAB systems.
- Gas loss alarms can be absolute or relative.
- An absolute alarm compares the current gas pressure against a fixed pressure limit. To avoid false alarms due to the variability of temperature and volume, the absolute alarm limits must be large, on the order of three to five cubic centimeters per hour.
- U.S. Pat. No. 3,698,381, issued to Federico et al. is an example of an absolute alarm system.
- Frederico et al. disclose an absolute leak detection method for an intra-aortic balloon catheter which involves monitoring the pressure of the shuttle gas just prior to inflation of the balloon. Leaks are detected on a beat-to-beat basis by comparing the measured pressure to fixed alarm limits. If the pressure of any single heartbeat is outside the fixed alarm or prescribed limits an alarm is declared. As discussed, the leak detection disclosed by Federico et al. is likely to cause false alarms because the effect of temperature is completely ignored.
- a “relative” or differential gas alarm checks for gas loss from a known datum.
- the datum is an initial shuttle gas pressure measurement taken when the system is deemed leak free. After this initial datum is taken it is compared to subsequent pressure readings to determine if gas loss has occurred. An alarm is issued if the difference between the datum and a new reading exceeds a predefined limit.
- the sensitivity of a relative gas alarm can be much higher than the absolute alarm because the initial datum implicitly includes the effects of current ambient temperature. This initial datum also implicitly captures the effect of tolerance of volumes. However, unless proper steps are taken, it does not include the effect of the thermodynamic temperature transient component induced by pumping.
- the present invention comprises a differential leak detection method for an IAB catheter for detecting the loss of shuttle gas due to an IAB perforation. Perforations are typically due to abrasion of the IAB membrane by aortic plaque, and occur after an initial, leak free interval of pumping.
- the detection method accounts for the effects of the thermodynamic temperature transient induced by pumping by comparing shuttle gas pressure readings, taken just prior to IAB inflation, with similar thermodynamic histories, i.e. similar equilibrium times.
- the invention is a leak detector for an intra-aortic balloon pump system comprising a processor, a pressure sensor, and optionally a temperature sensor. Gas leaks from the intra-aortic balloon pump system are detected by comparing shuttle gas pressure readings, taken just prior to IAB inflation, with similar thermodynamic histories, i.e. similar equilibrium times.
- FIG. 1 is block and partly schematic diagram of the present invention.
- FIG. 1 illustrates a block diagram of the present invention, generally designated 10 , comprising an intra-aortic balloon 12 , an intra-aortic balloon pump 14 , an intra-aortic balloon catheter 16 connecting said intra-aortic balloon pump 14 and said intra-aortic balloon 12 , a processor 18 connected to said intra-aortic balloon pump 14 , a memory unit 20 and a sensor 22 both connected to the processor 18 .
- Processor 18 can take the form of a computer, a more simplified circuit or control device, or can be part of the control device built into the intra-aortic balloon pump 14 .
- the intra-aortic balloon pump 14 shuttles a gas, generally helium, back and forth into the intra-aortic balloon 12 .
- a pressure reading is taken by sensor 22 preferably just prior to the inflation of intra-aortic balloon 12 .
- This timing of the reading allows for the longest amount of time for the shuttle gas pressure to stabilize, i.e. achieve static conditions and thermal equilibrium. This timing also assures that the volume of shuttle gas is known because at this time the shuttle gas resides in mechanical elements of known geometry, i.e. intra-aortic balloon pump 14 and intra-aortic balloon catheter 16 .
- Pressure measurements can be taken at other points in time but it is preferred that they are taken at the same point in each inflate/deflate cycle of intra-aortic balloon 12 .
- the pressure readings are stored in memory unit 20 .
- affiliated data may also stored in memory unit 20 , including but not limited to the inflate and deflate durations of intra-aortic balloon 12 and the time of occurrence of the heartbeat.
- the duration of the deflate interval is defined as the duration the balloon remains in the deflated state during systole plus the amount of time it takes for the balloon to deflate.
- the duration of the inflate interval is defined as the duration the balloon remains in the inflated state during diastole plus the amount of time it takes for the balloon to inflate.
- Processor 18 sorts all of the pressure measurements by the duration of the inflate/deflate intervals from which the pressure measurements were taken.
- processor 18 Periodically, processor 18 subtracts “similar” pressure readings, i.e. pressure readings taken from intra-aortic balloon 12 cycles having similar inflate/deflate durations. Processor 18 preferably uses the pressure readings having the most similar inflate/deflate durations. An alarm condition is declared if any of the differences exceed a fixed limit. Also periodically, the processor may eliminate from the memory unit 20 data read from heartbeats that are too old, i.e heartbeats for which the assumption of constant ambient temperature is invalid.
- the determination as to whether pressure readings are “similar” may be made by comparing intra-aortic balloon 12 deflate interval durations or preferably both inflate and deflate interval durations.
- Inflate/deflate intervals of similar duration have thermal transients of similar amplitude and character. Consequently, when pressure readings from similar interval durations are subtracted, the component of the pressure reading due to transient thermal energy subtracts out. Accordingly, any residual pressure difference is due to a loss of gas. If the pressure difference is found to be excessive, then an alarm is issued.
- the term “similar” with respect to inflate/deflate interval durations can mean any interval chosen specifically so as to reduce the transient thermal energy component to the pressure measurement. Note that it is preferable to select the longest deflate durations for use in alarm detection because (i) the decay of the thermal transient is more complete and (ii) the gas is more likely to have reached a static state, i.e. the time available for IAB deflation is maximized. Consequently, when pressure readings from long duration heartbeats are compared (subtracted), the residual errors due to these effects are minimized. Similarly, in the event that there is a residual component in the measured pressure due to shuttle gas flow, an additional benefit of this approach is that it also tends to subtract out, provided that identical deflation intervals are subtracted.
- the present invention comprises at least two types of gas alarms, namely, a slow gas alarm and a rapid gas alarm.
- processor 18 compares “similar” pressure readings that meet two criteria. First, the pressure readings must taken from inflate/deflate intervals of similar duration. Second, the readings are preferably from heartbeats which were captured close in time, e.g. heartbeat data captured within a one to five minute interval or preferably within a one to three minute interval. If the pressure drop between these beats exceed a predetermined alarm limit, then a rapid gas loss event is declared.
- the sensitivity of the rapid gas loss alarm is highest for a number of reasons.
- the pressure measurements must be compared over a longer period of time.
- the pressure measurements taken from heartbeats of similar duration, are stored and periodically plotted against time by processor 18 .
- the slope of the plot is used as an indicator of the rate of gas loss.
- IAB membranes and pump materials are permeable to diffusion of helium. Consequently, there is an expected slow loss of shuttle gas to the diffusion process. A slow gas alarm is issued when either the rate or total amount of shuttle gas loss exceeds the expected limits.
- each plot may also be useful to maintain multiple plots, each plot being computed from data relating to a specific heart rate or narrow range of heart rates. In this case, each plot would provide its own estimate of current slow gas rate.
- the pressure readings are not adjusted for the effects of temperature and also are taken at random points in the inflate/deflate cycle of the intra-aortic balloon 12 .
- the underlying basis of the present device and method disclosed is that when “similar” pressure readings are used, i.e. pressure readings measured at the same point in inflate/deflate intervals of similar durations, the transient temperature effect, due the lack of thermal equilibration, will subtract out.
- the sensitivity of the slow gas alarm can be improved by using a temperature sensor (not shown in FIG. 1) to measure local ambient temperature or preferably average shuttle gas pressure.
- the sensor's reading is then used, in conjunction with the Ideal Gas Law, to compute an adjusted pressure reading for each heart beat.
- the adjusted readings are then stored along with their associated durations and periodically plotted against time by the processor 18 .
- the slope of the plot is used as an indicator of the rate of gas loss. Note that in this case, a fast responding temperature sensor is not required since we are using the temperature readings to correct only for the slow effect of ambient temperature.
- the effect of thermal transients is excluded by limiting computations and comparisons to measurements of like durations.
- shuttle gas may also include a fluid or any other medium known in the art useful for inflating and deflating an expandable chamber. In reference to an IAB catheter, Helium is the preferred shuttle gas.
- the present invention is not limited to use with intra-aortic balloon catheters. Any pressurized cardiac assist device having one or more chambers being filled and evacuated of a working fluid, such as gas, may benefit from the enhanced pressure loss or gain sensitivity realized through use of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- External Artificial Organs (AREA)
Abstract
An intra-aortic balloon pump system having a leak detector comprising a processor, a pressure sensor, and optionally a temperature sensor. Gas leaks from the intra-aortic balloon pump system are detected by comparing shuttle gas pressure readings, taken just prior to IAB inflation, with similar thermodynamic histories, i.e. similar equilibrium times.
Description
- This application is a divisional application of application Ser. No. 09/903,447, filed on Jul. 11, 2001, which is a continuation-in-part application of application Ser. No. 09/339,492, filed on Jun. 24, 1999, all herein incorporated by reference.
- 1. Field of the Invention
- The invention relates to a leak detector for a pressurized device. More particularly, the invention relates to a detector for detecting a gas leak from an intra-aortic balloon (“IAB”) catheter system.
- 2. Description of the Prior Art
- In counterpulsation therapy, a long cylindrical intra-aortic balloon is inserted percutaneously into a patient's femoral artery. The balloon is then advanced until it is located in the descending aorta. Once in place, the balloon is inflated and deflated anti-phase to the pumping action of the patient's left ventricle, i.e. the balloon is held inflated during at least a portion of diastole and is held deflated during at least a portion of systole. The IAB catheter is connected to a pump (IABP) for inflation and deflation of the balloon membrane on the distal end of the catheter.
- IAB therapy is most effective when the transitions between the inflated and deflated states of the balloon membrane are rapid, typically, less than 0.1 second. When inflated and deflated in this manner, coronary blood flow is increased and cardiac work is decreased. This lifesaving therapy supports the heart during ischemic events or cardiogenic shock.
- When sized for adult patients, the IAB balloon typically has a volume of 40 cubic centimeters. A small diameter catheter having an outside diameter of less than 0.1 inches (2.5 mm) is integral to the IAB. The catheter provides pneumatic access to the IAB. By design, the catheter's diameter is small to reduce its impact upon blood flow in the patient's femoral artery. As a result, the catheter's small internal diameter impedes the flow of shuttle gas to and from the IAB balloon. Also, the catheter's pressure drop at the catheter and balloon junction is large because the gas velocity in the catheter is high, approximately 500 ft/sec.
- To reduce the impact of these effects: (1) helium gas is used as the working (shuttle) gas to inflate and deflate the IAB; and (2) a larger diameter “extension” catheter is used to interconnect the IAB's catheter to the intra-aortic balloon pump's pneumatic port. The extension catheter's diameter is larger, and thus, it's pressure drop is lower.
- During the pumping process, the shuttle gas is pressurized and de-pressurized each heartbeat by the IAB pump. The sources of the pressure changes are the pump and the restriction of the IAB's catheter. As a thermodynamic consequence, on each inflation of the IAB, heat energy is stored in the shuttle gas, and on each deflation, heat is released.
- Consequently, after each inflation or deflation event, the shuttle gas pressure changes as it attempts to thermally equilibrate with its environment. Typically, the pressure decays toward the appropriate average shuttle pressure in an exponential manner with a time constant on the order of approximately 1 second.
- During IAB therapy, thermal equilibrium is not achieved because the durations of IAB inflation and deflation are too brief, i.e. the shuttle gas is re-compressed before it “recovers” from deflation and vice versa. The durations of the deflate and inflate intervals, are approximately 0.375 seconds at a typical patient heart rate of 80 beats per minute. The duration of the deflate interval is defined as the duration the balloon remains in the deflated state during systole plus the amount of time it takes for the balloon to deflate. The duration of the inflate interval is defined as the duration the balloon remains in the inflated state during diastole plus the amount of time it takes for the balloon to inflate.
- If the shuttle gas leaks out of the IABP system, the IAB will not fully inflate. This diminishes therapy and can be harmful if gas is lost to the patient's blood stream. Accordingly, there is a need for detection of gas leaks from the IAB system's shuttle gas system. Detection systems have been incorporated into most existing IABP systems.
- In principle, detection of gas loss appears straightforward. In accordance to the Ideal Gas Law, the quantity (mass) of a gas in a known volume can be determined by measurement of its static pressure, and temperature.
- Accordingly, for leak detection using the Ideal Gas Law, IABP systems have a shuttle gas pressure sensor. To meet the Law's “known volume” requirement, the shuttle gas pressure is measured when the IAB is in its deflated state. This assures that the gas resides in the more stable and predicable geometries of the catheter(s) and intra-aortic balloon pump's drive.
- To meet the Law's static pressure criteria, the shuttle gas pressure is measured as “late” as possible after IAB deflation. This maximizes the time interval available for IAB deflation. When the IAB is fully deflated, the shuttle gas is no longer moving and the “static” criteria is met. This corresponds to measuring the pressure just prior to IAB inflation.
- The Law's final criteria, measurement of shuttle gas temperature, is more difficult to adequately satisfy. This is because the shuttle gas temperature is the sum of two components, a local ambient temperature component and a thermal transient component, due to gas compression and decompression. Temperature sensors with the necessary speed of response to measure the thermal transients are fragile and expensive. For this reason, shuttle temperature is not measured by most IAB systems.
- When the Ideal Gas Law is used for leak detection, and the effect of temperature is ignored, it is mathematically equivalent to assuming that the gas temperature is constant. In the case of local ambient temperature (average shuttle gas temperature), this is likely to be true if leak detection comparisons are limited to readings which were taken close in time. This is true if one presumes that the ambient's effect upon the average temperature of the shuttle gas is slow, i.e. on the order of minutes.
- However, in the case of the thermal transient component, it is not sufficient to compare heartbeats taken at similar times. An additional criteria must be added to avoid false alarms. This is a consequence of the thermal transient's effect upon shuttle gas pressure. Specifically, after the gas is decompressed, its pressure exponentially decays toward the average shuttle gas pressure level. Typically, a leak detection pressure measurement is taken before this decay process is complete. As a result, the pressure reading has a transient component whose value depends upon the time when the reading was taken, relative the decompression event. Comparisons of pressure readings with different decay times result in false leak detection alarms, unless the alarm's limits are made larger, and thus less sensitive, to exclude these errors.
- Gas loss alarms can be absolute or relative. An absolute alarm compares the current gas pressure against a fixed pressure limit. To avoid false alarms due to the variability of temperature and volume, the absolute alarm limits must be large, on the order of three to five cubic centimeters per hour.
- U.S. Pat. No. 3,698,381, issued to Federico et al., is an example of an absolute alarm system. Frederico et al. disclose an absolute leak detection method for an intra-aortic balloon catheter which involves monitoring the pressure of the shuttle gas just prior to inflation of the balloon. Leaks are detected on a beat-to-beat basis by comparing the measured pressure to fixed alarm limits. If the pressure of any single heartbeat is outside the fixed alarm or prescribed limits an alarm is declared. As discussed, the leak detection disclosed by Federico et al. is likely to cause false alarms because the effect of temperature is completely ignored.
- A “relative” or differential gas alarm checks for gas loss from a known datum. The datum is an initial shuttle gas pressure measurement taken when the system is deemed leak free. After this initial datum is taken it is compared to subsequent pressure readings to determine if gas loss has occurred. An alarm is issued if the difference between the datum and a new reading exceeds a predefined limit.
- The sensitivity of a relative gas alarm can be much higher than the absolute alarm because the initial datum implicitly includes the effects of current ambient temperature. This initial datum also implicitly captures the effect of tolerance of volumes. However, unless proper steps are taken, it does not include the effect of the thermodynamic temperature transient component induced by pumping.
- The present invention comprises a differential leak detection method for an IAB catheter for detecting the loss of shuttle gas due to an IAB perforation. Perforations are typically due to abrasion of the IAB membrane by aortic plaque, and occur after an initial, leak free interval of pumping. The detection method accounts for the effects of the thermodynamic temperature transient induced by pumping by comparing shuttle gas pressure readings, taken just prior to IAB inflation, with similar thermodynamic histories, i.e. similar equilibrium times.
- Accordingly, it is an object of the invention to produce a leak detector for an IAB system capable of making an accurate leak detection, by measuring changes in the gas pressure, despite thermodynamic variations in the shuttle gas temperature and the mechanical tolerances on pump volumes.
- The invention is a leak detector for an intra-aortic balloon pump system comprising a processor, a pressure sensor, and optionally a temperature sensor. Gas leaks from the intra-aortic balloon pump system are detected by comparing shuttle gas pressure readings, taken just prior to IAB inflation, with similar thermodynamic histories, i.e. similar equilibrium times.
- To the accomplishment of the above and related objects the invention may be embodied in the form illustrated in the accompanying drawings. Attention is called to the fact, however, that the drawings are illustrative only. Variations are contemplated as being part of the invention, limited only by the scope of the claims.
- In the drawings, like elements are depicted by like reference numerals. The drawings are briefly described as follows.
- FIG. 1 is block and partly schematic diagram of the present invention.
- FIG. 1 illustrates a block diagram of the present invention, generally designated10, comprising an
intra-aortic balloon 12, anintra-aortic balloon pump 14, anintra-aortic balloon catheter 16 connecting saidintra-aortic balloon pump 14 and saidintra-aortic balloon 12, aprocessor 18 connected to saidintra-aortic balloon pump 14, amemory unit 20 and asensor 22 both connected to theprocessor 18.Processor 18 can take the form of a computer, a more simplified circuit or control device, or can be part of the control device built into theintra-aortic balloon pump 14. The intra-aortic balloon pump 14 shuttles a gas, generally helium, back and forth into theintra-aortic balloon 12. For each heartbeat of a patient, a pressure reading is taken bysensor 22 preferably just prior to the inflation ofintra-aortic balloon 12. This timing of the reading allows for the longest amount of time for the shuttle gas pressure to stabilize, i.e. achieve static conditions and thermal equilibrium. This timing also assures that the volume of shuttle gas is known because at this time the shuttle gas resides in mechanical elements of known geometry, i.e.intra-aortic balloon pump 14 andintra-aortic balloon catheter 16. Pressure measurements can be taken at other points in time but it is preferred that they are taken at the same point in each inflate/deflate cycle ofintra-aortic balloon 12. - The pressure readings are stored in
memory unit 20. Affiliated data may also stored inmemory unit 20, including but not limited to the inflate and deflate durations ofintra-aortic balloon 12 and the time of occurrence of the heartbeat. The duration of the deflate interval is defined as the duration the balloon remains in the deflated state during systole plus the amount of time it takes for the balloon to deflate. The duration of the inflate interval is defined as the duration the balloon remains in the inflated state during diastole plus the amount of time it takes for the balloon to inflate.Processor 18 sorts all of the pressure measurements by the duration of the inflate/deflate intervals from which the pressure measurements were taken. Periodically,processor 18 subtracts “similar” pressure readings, i.e. pressure readings taken fromintra-aortic balloon 12 cycles having similar inflate/deflate durations.Processor 18 preferably uses the pressure readings having the most similar inflate/deflate durations. An alarm condition is declared if any of the differences exceed a fixed limit. Also periodically, the processor may eliminate from thememory unit 20 data read from heartbeats that are too old, i.e heartbeats for which the assumption of constant ambient temperature is invalid. - The determination as to whether pressure readings are “similar” may be made by comparing
intra-aortic balloon 12 deflate interval durations or preferably both inflate and deflate interval durations. - Inflate/deflate intervals of similar duration have thermal transients of similar amplitude and character. Consequently, when pressure readings from similar interval durations are subtracted, the component of the pressure reading due to transient thermal energy subtracts out. Accordingly, any residual pressure difference is due to a loss of gas. If the pressure difference is found to be excessive, then an alarm is issued.
- The more similar the interval durations for the pressure measurements chosen are the more accurate the gas loss determination will be. Accordingly, it is preferred to compare pressure measurements from the most similar interval durations. However, the term “similar” with respect to inflate/deflate interval durations can mean any interval chosen specifically so as to reduce the transient thermal energy component to the pressure measurement. Note that it is preferable to select the longest deflate durations for use in alarm detection because (i) the decay of the thermal transient is more complete and (ii) the gas is more likely to have reached a static state, i.e. the time available for IAB deflation is maximized. Consequently, when pressure readings from long duration heartbeats are compared (subtracted), the residual errors due to these effects are minimized. Similarly, in the event that there is a residual component in the measured pressure due to shuttle gas flow, an additional benefit of this approach is that it also tends to subtract out, provided that identical deflation intervals are subtracted.
- The present invention comprises at least two types of gas alarms, namely, a slow gas alarm and a rapid gas alarm. To test for the rapid loss of gas,
processor 18 compares “similar” pressure readings that meet two criteria. First, the pressure readings must taken from inflate/deflate intervals of similar duration. Second, the readings are preferably from heartbeats which were captured close in time, e.g. heartbeat data captured within a one to five minute interval or preferably within a one to three minute interval. If the pressure drop between these beats exceed a predetermined alarm limit, then a rapid gas loss event is declared. - The sensitivity of the rapid gas loss alarm is highest for a number of reasons. First, comparing heartbeats of similar duration eliminates the effect of the thermal transient pressure component. Second, comparing heartbeats taken close together in time eliminates the effect of local ambient temperature. When heartbeats taken close together in time are subtracted, the effect of local ambient temperature is eliminated, i.e. it subtracts out. Since the effects of ambient temperature and thermal transients are eliminated, the sensitivity of this alarm exceeds that of a fixed alarm system.
- As discussed above, Federico et al. compare pressure readings to a fixed alarm limit, irrespective of their duration or proximity in time. Consequently, to avoid false alarms due ambient temperature and thermal transients, the alarm limit is necessarily larger and thus, less sensitive.
- To test for the slow loss of gas, the pressure measurements must be compared over a longer period of time. The pressure measurements, taken from heartbeats of similar duration, are stored and periodically plotted against time by
processor 18. The slope of the plot is used as an indicator of the rate of gas loss. Typically, IAB membranes and pump materials are permeable to diffusion of helium. Consequently, there is an expected slow loss of shuttle gas to the diffusion process. A slow gas alarm is issued when either the rate or total amount of shuttle gas loss exceeds the expected limits. - It may also be useful to maintain multiple plots, each plot being computed from data relating to a specific heart rate or narrow range of heart rates. In this case, each plot would provide its own estimate of current slow gas rate.
- In current intra-aortic balloon pump systems, the pressure readings are not adjusted for the effects of temperature and also are taken at random points in the inflate/deflate cycle of the
intra-aortic balloon 12. The underlying basis of the present device and method disclosed is that when “similar” pressure readings are used, i.e. pressure readings measured at the same point in inflate/deflate intervals of similar durations, the transient temperature effect, due the lack of thermal equilibration, will subtract out. - Given the elimination of the transient thermal pressure component, if the subtraction of pressure readings yields a significant difference it must be due to a gas loss or gain. In the case of the slow gas alarm, pressure readings from heart beats which are not in close proximity in time are compared. Consequently, the alarm is vulnerable to changes in local ambient temperature. For this reason, the slow gas alarm is less sensitive than the rapid gas alarm. Often, the pump's local ambient temperature is relatively constant. In this case, the effects of ambient temperature subtract out.
- The sensitivity of the slow gas alarm can be improved by using a temperature sensor (not shown in FIG. 1) to measure local ambient temperature or preferably average shuttle gas pressure. The sensor's reading is then used, in conjunction with the Ideal Gas Law, to compute an adjusted pressure reading for each heart beat. As in the above, the adjusted readings are then stored along with their associated durations and periodically plotted against time by the
processor 18. The slope of the plot is used as an indicator of the rate of gas loss. Note that in this case, a fast responding temperature sensor is not required since we are using the temperature readings to correct only for the slow effect of ambient temperature. The effect of thermal transients is excluded by limiting computations and comparisons to measurements of like durations. - Note that it is anticipated to use the present invention for the detection of gas gains, i.e. a leak of gas into the shuttle gas system. This can occur if there is a leak to atmospheric pressure or if there is a leakage into the system due to the failure of one or
more IABP 14 helium fill valves (not shown). Note also that the term shuttle gas may also include a fluid or any other medium known in the art useful for inflating and deflating an expandable chamber. In reference to an IAB catheter, Helium is the preferred shuttle gas. - Note also that the present invention is not limited to use with intra-aortic balloon catheters. Any pressurized cardiac assist device having one or more chambers being filled and evacuated of a working fluid, such as gas, may benefit from the enhanced pressure loss or gain sensitivity realized through use of the present invention.
- As many apparently widely different embodiments of the present invention can be made without departing from the spirit and scope thereof, it is to be understood that the invention is not limited to the specific embodiments thereof except as defined in the appended claims.
Claims (11)
1. A leak detector device for a pressurized cardiac assist device for use on a patient comprising a processor and a pressure sensor communicating with said processor for sensing the pressure of a gas in said pressurized cardiac assist device, said pressurized cardiac assist device comprising one or more chambers, said one or more chambers being filled and evacuated of the gas by a pump, during therapy said one or more chambers being maintained in an evacuated state during at least a portion of the patient's heartbeat and being maintained in a filled state during at least a portion of a patient's heartbeat, the processor comparing pressure measurements taken by the pressure sensor from different fill/evacuation cycles having similar evacuation interval durations and indicating a pressure loss or gain if the pressure measurements vary beyond a predetermined level.
2. The device as claimed in claim 2 wherein the processor compares pressure measurements taken by the pressure sensor from fill/evacuation cycles of the one or more chambers having similar fill and evacuation interval durations.
3. A leak detector device for a pressurized cardiac assist device for use on a patient comprising a processor and a pressure sensor communicating with said processor for sensing the pressure of a gas in said pressurized cardiac assist device, said pressurized cardiac assist device comprising one or more chambers, said one or more chambers being filled and evacuated of the gas by a pump, during therapy said one or more chambers being maintained in an evacuated state during at least a portion of the patient's heartbeat and being maintained in a filled state during at least a portion of a patient's heartbeat, the processor comparing pressure measurements taken by the pressure sensor from different fill/evacuation cycles having similar fill interval durations and indicating a pressure loss or gain if the pressure measurements vary beyond a predetermined level.
4. The leak detector device as claimed in claim 1 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube.
5. The leak detector device as claimed in claim 3 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube.
6. The leak detector device as claimed in claim 1 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube, the processor measures the gas pressure in the balloon catheter at the same point in a plurality of fill/evacuation cycles of the balloon.
7. The leak detector device as claimed in claim 3 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube, the processor measures the gas pressure in the balloon catheter at the same point in a plurality of fill/evacuation cycles of the balloon.
8. The leak detector device as claimed in claim 1 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube, the processor compares pressure measurements taken just prior to the fill of the balloon.
9. The leak detector device as claimed in claim 3 wherein the cardiac assist device comprises a balloon catheter, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube, the processor compares pressure measurements taken just prior to the fill of the balloon.
10. The leak detector device as claimed in claim 1 wherein the cardiac assist device comprises a balloon catheter and a memory unit connected to the processor for storing pressure measurements, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube.
11. The leak detector device as claimed in claim 3 wherein the cardiac assist device comprises a balloon catheter and a memory unit connected to the processor for storing pressure measurements, said balloon catheter comprising a tube connected on one end to a balloon membrane, and wherein the chamber comprises a volume defined by the balloon membrane and the pump being connected to the tube.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/341,983 US20030101800A1 (en) | 1999-06-24 | 2003-01-14 | Balloon catheter leak detection method and apparatus |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33949299A | 1999-06-24 | 1999-06-24 | |
US09/903,447 US6536260B2 (en) | 1999-06-24 | 2001-07-11 | Balloon catheter leak detection method and apparatus |
US10/341,983 US20030101800A1 (en) | 1999-06-24 | 2003-01-14 | Balloon catheter leak detection method and apparatus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/903,447 Division US6536260B2 (en) | 1999-06-24 | 2001-07-11 | Balloon catheter leak detection method and apparatus |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030101800A1 true US20030101800A1 (en) | 2003-06-05 |
Family
ID=26991654
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/903,447 Expired - Fee Related US6536260B2 (en) | 1999-06-24 | 2001-07-11 | Balloon catheter leak detection method and apparatus |
US10/341,983 Pending US20030101800A1 (en) | 1999-06-24 | 2003-01-14 | Balloon catheter leak detection method and apparatus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/903,447 Expired - Fee Related US6536260B2 (en) | 1999-06-24 | 2001-07-11 | Balloon catheter leak detection method and apparatus |
Country Status (1)
Country | Link |
---|---|
US (2) | US6536260B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070027393A1 (en) * | 2005-08-01 | 2007-02-01 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
EP2353632A1 (en) * | 2010-02-09 | 2011-08-10 | Sanofi-Aventis Deutschland GmbH | Medical device for local drug delivery |
CN104483079A (en) * | 2014-11-29 | 2015-04-01 | 农业部沼气科学研究所 | Biogas tank airtightness testing device |
US20160367306A1 (en) * | 2005-03-07 | 2016-12-22 | Medtronic Cryocath Lp | Fluid control system for a medical device |
JP2022092179A (en) * | 2020-12-10 | 2022-06-22 | 公益財団法人がん研究会 | Suction type patient fastener leak detector, detection system, and detection method |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
US8540618B2 (en) | 2003-01-31 | 2013-09-24 | L-Vad Technology, Inc. | Stable aortic blood pump implant |
US8721515B2 (en) * | 2003-01-31 | 2014-05-13 | L-Vad Technology, Inc. | Rigid body aortic blood pump implant |
US8075540B2 (en) * | 2004-11-09 | 2011-12-13 | Hollister Incorporated | Bowel management system with physiologic sensors |
US7210337B1 (en) * | 2005-10-17 | 2007-05-01 | Honeywell International Inc. | MEMS sensor package leak test |
US20080077225A1 (en) * | 2006-09-22 | 2008-03-27 | Carlin Donald B | Accuracy lumen sizing and stent expansion |
US8100880B2 (en) | 2007-04-05 | 2012-01-24 | Velomedix, Inc. | Automated therapy system and method |
WO2009001328A2 (en) * | 2007-06-27 | 2008-12-31 | Flip Technologies Limited | A system, device and a method for dilating a stricture in a lumen and for determining the transverse cross-sectional area of a lumen or cavity |
JP5410423B2 (en) | 2007-07-09 | 2014-02-05 | ベロメディックス,インク | Hypothermia apparatus and method |
JP5107065B2 (en) * | 2008-01-15 | 2012-12-26 | オリンパスメディカルシステムズ株式会社 | Inner diameter measuring tool |
WO2012122267A1 (en) | 2011-03-07 | 2012-09-13 | Theranova, Llc | Sensing foley catheter |
US20110092955A1 (en) | 2009-10-07 | 2011-04-21 | Purdy Phillip D | Pressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices |
US8529562B2 (en) * | 2009-11-13 | 2013-09-10 | Minerva Surgical, Inc | Systems and methods for endometrial ablation |
US9132064B2 (en) * | 2009-12-23 | 2015-09-15 | Avent, Inc. | Enteral feeding catheter assembly incorporating an indicator |
WO2012006625A2 (en) * | 2010-07-09 | 2012-01-12 | Velomedix, Inc. | Method and apparatus for pressure measurement |
US8439862B2 (en) | 2010-12-10 | 2013-05-14 | Kimberly-Clark Worldwide, Inc. | Infusion apparatus with flow indicator |
US8142394B1 (en) | 2010-12-23 | 2012-03-27 | Kimberly-Clark Worldwide, Inc. | Enteral feeding catheter device with an indicator |
WO2014099527A1 (en) | 2012-12-17 | 2014-06-26 | Theranova, Llc | Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis |
US10206802B2 (en) | 2011-03-07 | 2019-02-19 | Theranova, Llc | Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis |
CN103635133B (en) | 2011-06-30 | 2016-01-20 | 甘布罗伦迪亚股份公司 | The filtering of time correlation pressure signal |
US9869603B2 (en) | 2012-09-27 | 2018-01-16 | Redline Detection, Llc | Balloon catheter apparatus for internal combustion engine component leak detection and high pressure leak detection |
US9417153B2 (en) * | 2012-09-27 | 2016-08-16 | Redline Detection, Llc | Balloon catheter apparatus for high pressure leak detection |
CN103892819A (en) * | 2012-12-26 | 2014-07-02 | 广州医学院第一附属医院 | Pressure reactivity detection device of double-balloon catheters |
WO2016049654A1 (en) | 2014-09-28 | 2016-03-31 | Potrero Medical, Inc. | Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids |
JP6459760B2 (en) * | 2015-04-30 | 2019-01-30 | 株式会社カネカ | Catheter hub, connection structure and pressure-resistant inspection device |
US9933326B2 (en) | 2015-07-22 | 2018-04-03 | Redline Detection, Llc | System and method for detecting microscopic leaks |
US11268875B2 (en) | 2016-11-22 | 2022-03-08 | Redline Detection, Llc | Method and apparatus for fluid leak detection |
US20240085266A1 (en) * | 2022-09-09 | 2024-03-14 | Zaxis, Inc. | Systems and methods for providing a volumetric detection system |
CN116296084B (en) * | 2023-03-18 | 2023-10-27 | 南通安琪医疗用品有限公司 | High polymer material catheter tightness detection device |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3359974A (en) * | 1963-10-07 | 1967-12-26 | Hassan H Khalil | Device for the thermal determination of cardiac volumetric performance |
US3698381A (en) * | 1970-12-30 | 1972-10-17 | Avco Corp | Monitoring system for physiological support systems |
US3720199A (en) * | 1971-05-14 | 1973-03-13 | Avco Corp | Safety connector for balloon pump |
US4175264A (en) * | 1975-03-06 | 1979-11-20 | Peter Schiff | Electronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart |
US4522194A (en) * | 1983-02-18 | 1985-06-11 | Baylor College Of Medicine | Method and an apparatus for intra-aortic balloon monitoring and leak detection |
US4969470A (en) * | 1984-02-27 | 1990-11-13 | Boston Scientific Corporation | Heart analysis using pressure-controlled intermittent coronary sinus occlusion |
US5720293A (en) * | 1991-01-29 | 1998-02-24 | Baxter International Inc. | Diagnostic catheter with memory |
JPH04303459A (en) * | 1991-03-29 | 1992-10-27 | Aisin Seiki Co Ltd | Drive gas leakage detecting device for in-main artery balloon pump |
US5513956A (en) * | 1994-01-14 | 1996-05-07 | Arrow International Investment Corp. | Circulatory assisted device with motor driven gas pump |
WO1997022373A1 (en) * | 1995-12-18 | 1997-06-26 | Nippon Zeon Co., Ltd. | Drive unit for medical equipment |
-
2001
- 2001-07-11 US US09/903,447 patent/US6536260B2/en not_active Expired - Fee Related
-
2003
- 2003-01-14 US US10/341,983 patent/US20030101800A1/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160367306A1 (en) * | 2005-03-07 | 2016-12-22 | Medtronic Cryocath Lp | Fluid control system for a medical device |
US10022175B2 (en) * | 2005-03-07 | 2018-07-17 | Medtronic Cryocath Lp | Fluid control system for a medical device |
US20070027393A1 (en) * | 2005-08-01 | 2007-02-01 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
US7771362B2 (en) * | 2005-08-01 | 2010-08-10 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
US20100312126A1 (en) * | 2005-08-01 | 2010-12-09 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
US8133184B2 (en) * | 2005-08-01 | 2012-03-13 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
EP2353632A1 (en) * | 2010-02-09 | 2011-08-10 | Sanofi-Aventis Deutschland GmbH | Medical device for local drug delivery |
CN104483079A (en) * | 2014-11-29 | 2015-04-01 | 农业部沼气科学研究所 | Biogas tank airtightness testing device |
JP2022092179A (en) * | 2020-12-10 | 2022-06-22 | 公益財団法人がん研究会 | Suction type patient fastener leak detector, detection system, and detection method |
JP7421467B2 (en) | 2020-12-10 | 2024-01-24 | 公益財団法人がん研究会 | Suction type patient fixture leak detector, detection system, and detection method |
Also Published As
Publication number | Publication date |
---|---|
US20010035046A1 (en) | 2001-11-01 |
US6536260B2 (en) | 2003-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6536260B2 (en) | Balloon catheter leak detection method and apparatus | |
US3985123A (en) | Method and means for monitoring cardiac output | |
US4360029A (en) | Automatic mean blood pressure reading device | |
US4349034A (en) | Automatic mean blood pressure reading device | |
EP0096495B1 (en) | Cardiac flow measurement system and method | |
US9612182B2 (en) | Method and device for detecting a fault condition | |
US5560366A (en) | Oscillometric blood pressure measuring apparatus | |
US5054494A (en) | Oscillometric blood pressure device | |
US5423323A (en) | System for calculating compliance and cardiac hemodynamic parameters | |
US3581734A (en) | Sphygmomanometer | |
US11246497B2 (en) | Method and computer system for processing a heart sensor output | |
Van de Werf et al. | The genesis of the third and fourth heart sounds. A pressure-flow study in dogs. | |
EP0353315B1 (en) | Method for measuring blood pressure and apparatus for automated blood pressure measuring | |
KR880002492A (en) | Automatic Blood Pressure Measuring Device and Method | |
Redwood et al. | Evaluation of the ability of echocardiography to measure acute alterations in left ventricular volume | |
US4870973A (en) | Electronic blood pressure meter having means for detecting artifacts | |
US4735213A (en) | Device and method for determining systolic blood pressure | |
JP2711019B2 (en) | Blood pressure measurement device | |
US5000187A (en) | Blood pressure measuring apparatus | |
US5220502A (en) | Automatic blood pressure measurement in hyperbaric chamber | |
JPS62189049A (en) | Balloon pump apparatus in main artery | |
US3623476A (en) | Blood pressure measurement apparatus | |
US4549549A (en) | Electronic sphygmomanometer | |
EP0150176B1 (en) | Blood pressure measurement with korotkov sound artifact information detection and rejection | |
KR100910591B1 (en) | Blood measuring pressure method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |